About FDA

Academic MOUs

MOU No.PurposePartiesFDA Lead Center or
Office/ Contact
Effective DateExpiration
Date
224-11-0024Establishes a collaborative framework between the FDA and the University of Florida through a variety of programs, including collaborative education and research. Term Extension Modification.University of FloridaCDER
Ryan Chatman
(301) 796-2106
09-21-201109-19-2021
225-02-8001Establishes terms of collaboration between FDA and UMD to support shared interest in scientific progress through a variety of programs such as sabbaticals, postdoctoral fellowships, and student internships.University of MDOC
Eileen Parish
(301) 796-8522
09-04-2002Indefinite
225-03-6000Establishes terms of collaboration between FDA and VA Polytechnic Institute to support shared interest in scientific progress through a variety of programs such as sabbaticals, postdoctoral fellowships, and student internships.University of HoustonCDRH
Michelle Chenault
(240) 276-3815
03-29-2003Indefinite
225-03-8002Establishes terms of collaboration between FDA and VA Polytechnic Institute to support shared interest in scientific progress through a variety of programs such as sabbaticals, postdoctoral fellowships, and student internships.VA Polytechnic
Institute
OC
Eileen Parish
(301) 796-8522
03-13-2003Indefinite
225-03-8003Establishes terms of collaboration between FDA and Howard University to support shared interest in scientific progress affecting human and animal health and medicine through a variety of programs such as sabbaticals, postdoctoral fellowships, and student internships.Howard UniversityOC
Eileen Parish
(301) 796-8522
05-29-2003Indefinite
225-04-4003Establishes a framework for collaborative research and development and emergency triage response efforts on the subject of Homeland Security.University of CA, Lawrence Livermore National LaboratoryORA
Jeanne Roman
(301) 827-0947
04-14-2004Indefinite
225-05-6000To establish terms of collaboration between FDA and BWH to support shared interests and to begin the initiative "The FDA Brigham Elective Program for Residents in the Department of Medicine."Brigham and Women's HospitalCDRH
Anindita Saha
(301) 796-2537
Mimi Nguyen
(301) 796-4125
05-09-2006 
225-05-6001Establishes collaboration between FDA, Duke University, and Duke University Health System, Inc. in sharing scientific information.Duke University

Duke University Health System, Inc.
CDRH
Annindita Saha
(301) 796-2537
Mimi Nguyen
301-796-4125
09-18-2006Indefinite
225-07-6001Establishes the terms for collaborative research between the FDA and Stanford University to promote scientific progress in animal and human medicine. Amended to change POC and termination date.Stanford UniversityCDRH
Anindita Saha
(301-796-2537
Mimi Nguyen
301-796-4125
05-11-2016Indefinite
225-07-8005To establish terms of collaboration between FDA and Duke, as a part of FDA's Critical Path Initiative. This MOU will serve as the basis of a Public Private Partnership hosted by Duke to systematically modernize the clinical trial process.Duke UniversityOC
Melissa Robb
(301) 827-1516
09-22-2007Indefinite
225-07-8008 -1
replaces
227-07-8008 and
225-02-8000
To establish collaboration in the areas of advanced scientific training, information exchange and stimulation of cooperative research activities in biotechnology, bioethics, and nanotechnology, particularly with the Institute of NanoBioTechnology.John Hopkins UniversityOC
Eileen Parish
(301) 796-8522
05-20-201505-20-2020
225-07-8405
Amendment #2
Establishes terms of collaboration between FDA and the University System of MD to support their shared interest in scientific progress in the diverse disciplines that directly and indirectly affect human and animal health medicine.University System of MDOC
Eileen Parish
(301) 796-8522
10/22/201210/21/2017
225-11-0022Establishes the terms for collaboration to promote shared interests, which can be pursued through a variety of programs including collaborative education research.The Hamner Institutes for Health Sciences' including The Hamner-UNC Institute for Drug Safety SciencesCDER
Ryan Chatman
(301) 796-2106
12-06-201112-06-2016
225-11-0011To promote scientific progress through exchange of scientific capital in Applied Physics Research in understanding continuous processing and control in micro reactors.University of WashingtonCDER
David Morley
(301) 796-1719
04-04-201104-04-2016
225-11-0003To set forth a framework for an alliance between FDA and GUMC. The MOU is intended to leverage the Parties' combined strengths, resources, and proximity for stimulating innovation in regulatory science, ethics, education, and training within the scope of FDA mission and the broad academic charge of GUMC.Georgetown University Medical CenterOC
Leslie D. Wheelock
(301) 796-8450
02-24-201102-24-2016
225-11-0006Establishes the terms for collaboration to promote shared interests, which can be pursued through a variety of programs including collaborative education researchRegents of the University of California, San FranciscoCDER
Ryan Chatman
(301) 796-2106
02-18-201102-18-2016
225-11-0010To establish a framework for an alliance between FDA-OIP and the O'Neill Institute.Georgetown University Law CenterOIP
Katherine Bond
(301) 796-8318
10-19-201110-19-2016
225-11-0012Forms the basis for the initial relations between FDA and the University of Hawaii for sabbaticals, research and scientific education.University of Hawaii at Manoa, Office of Public Health StudiesOMH
Jonca Bull, MD
(301) 796-8000
04-24-12Indefinite
225-11-0015The Food and Drug Administration (FDA) and the Harvard Medical School, Department of Population Medicine (Harvard), collaborate in promoting scientific progress through exchange of scientific capital in promoting postmarket safety surveillance research.Harvard Medical SchoolGerald J. Dal Pan, MD, MH
(301) 796-2380
09-30-201109-29-2016
225-11-0020Establishes the terms for collaboration to promote shared interests, which can be pursued through various programs including collaborative education and researchThe Trustees of Columbia University in the City of New YorkCDER
Mark Lauda
(301) 796-0381
10-19-201110-19-2016
225-11-0030Establishes the terms for The United States Food and Drug Administration (FDA) and Duke University (the Parties)to share interests in promoting scientific progress through exchange of scientific capital in an effort to enhance the assessment of safety and efficacy of FDA-regulated products.Duke UniversityCDER11-08-201111-08-2016
225-12-0002Establishes the terms for collaboration to promote these shared interests, which can be pursued through a variety of programs including collobrative research, public outreach, extension activities, cooperative international initiatives, and disciplinary training.Austen BioInnovation Institute in AkronCDRH
Michelle McMurry-Heath
(301) 796-7647
12-15-201112-15-2016
225-12-0004Establishes the collaboration between The United States Food and Drug Administration (FDA) and Thomas Jefferson University to share interests in promoting scientific progress through exchange of scientific capital in Clinical Pharmacology Training and Research Program. Time Extension AmendmentThe Thomas Jefferson UniversityCDER
Ryan Chatman
(301) 796-2106
12-09-201112-09-2021
225-12-0010Forms the basis betweenThe Food and Drug Administration (FDA) and the Massachusetts Institute of Technology (MIT)to collaborate in promoting scientific progress through exchange of scientific capital in training and research and foresee benefits from the mutual exchange of training and research expertise.Massachusetts Institute of Technology (MIT)CDER
Nancy Pluhlowski
(301) 796-6660
12-09-201104-15-2017
225-12-0011Forms the basis for the initial relations between FDA and the University of Hawaii, College of Pharmacy for sabbaticals, research and scientific educationUniversity of Hawaii Hilo, College of PharmacyOMH
Jonca Bull, MD
(301) 796-8000
03-30-2012Indefinite
225-12-0018Establishes the terms between the Food and Drug Administration (FDA) and Stanford University (Stanford) to promote scientific progress through exchange of scientific capital in diverse fields of science that affect human and animal health and medicine.Stanford UniversityGerald J. Dal Pan, MD MHS(301) 796-238005-17-2012Indefinite
225-12-0026Forms the basis for the initial relations between the FDA and The University of Nebraska (UNMC) for sabbaticals, research and scientific education.University of NebraskaOMH
Jonca Bull, MD
(301) 796-8000
06-28-201206-28-2017
225-12-0027Establishes terms of collaboration between U.S. Food and Drug Administration (FDA) and Harvard University, Joslin Diabetes Center to share interests in promoting scientific progress through exchange of scientific capital in epidemiology and research.Harvard University, Joslin Diabetes CenterJonca Bull, MD
(301) 796-8000
09-14-201209-13-2017
225-12-0029Forms the basis for the initial relations between FDA and Meharry Medical College (Meharry) for sabbaticals, research and scientific education.Meharry Medical CollegeOMH
Jonca Bull, MD
(301) 796-8000
06-21-2012Indefinite
225-12-0036Establishes terms of collaboration between The United States Food and Drug Administration (FDA) and the University of Medicine and Dentistry of New Jersey (UMDNJ) to share interests in promoting scientific progress through exchange of scientific capital in the clinical pharmacology training and research program. The New Jersey Medical and Health Sciences Education Restructuring Act provides for most schools and units of the University of Medicine and Dentistry of New Jersey, including the School of Health Related Professions, to be transferred to Rutgers, the State University of New Jersey (“Rutgers”) effective July 1, 2013. (Modification 1)University of Medicine and Dentistry of New Jersey (Transferred to Rutgers University)CDER06-19-201206-19-2017
225-12-0041Collaborate to develop strategic plans, set priorities, and leverage resources and expertise from multiple sources, including the private sector, toward the goals of identifying scientific gaps in the design, implementation and interpretation of clinical trials to improve analgesic, anesthetic, and addiction treatments for the benefit of the public health.University of RochesterCDER
Bob A. Rappaport, MD
04-29-201304-28-2018
225-93-2001IL Inst. Tech., participation in short courses, workshops, & training programs in food safety and technology.IL Inst. TechCFSAN
Don Zink
(240) 402-1693
09-03-1993Indefinite
225-12-8000Promoting scientific progress through knowledge exchange of scientific capital in pharmacology and translational research. Amended for time extension.The Systems Biology InstituteCDER
Darrell Abernathy, MD, PhD
(301) 796-5008
06-11-20126-09-2018
225-13-0002Establishes terms of collaboration between FDA and President and Fellows of Harvard College on behalf of the Harvard School of Public HealthHarvard School of Public HealthCDER
Nisha Bruce
(301) 796-0381
11-14-201211/13/2017
225-13-0004Promoting scientific progress through exchange of scientific capital in the areas of public health and regulatory research.University of North Carolina at Chapel HillNisha Bruce
(301) 796-0381
12-21-201212-21-2017
225-13-0020Establishes terms of collaboration between FDA and the University of Hamburg for development of scientific collaborations, outreach and educational initiatives, and intellectual partnerships.University of HamburgCFSAN
Eric Brown, PhD
(240) 402-2020
09-05-2013Indefinite
UMBCEstablishes terms of colla boration between FDA and UMBC to support collaboration on specific projects related to biotechnology process validation, but can serve as a basis for future collaboration in other areas.University of MD Baltimore CountyCDER
Dr. Kurt Brorson
(301) 796-2193
07-25-2003Indefinite
225-14-0005Establishes terms of collaboration between FDA and the President and Fellows of Harvard College on behalf of Harvard Medical School pursued through a variety of programs including collaborative research, public outreach, extension activities, cooperative international initiatives, and disciplinary training.President and Fellows of Harvard College on behalf of Harvard Medical SchoolCDRH
Danica Marinac-Dabic, MD, PhD
(301) 796-6689
04-08-201404-07-2019
225-14-0007(OC)This Memorandum of Understanding (MOU) states the mutual intention of the parties to seek opportunities for collaboration and to promote shared interests in various science-based academic initiatives, fellowships, and student internships.York College of the City University of New YorkOMH
Jonca Bull, MD
(301) 796-8000
02/20/2014Indefinite
225-14-014Promoting scientific progress through exchange of scientific capital in the areas of public health and regulatory research.Regents of the University of MinnesotaCDER
Mark Lauda
(301) 796-0381
09/04/201409/03/2019
225-14-8001Establishes terms of collaboration between FDA and the University of Cologne to share interests in promoting scientific progress through knowledge exchange of scientific capital in pharmacology and translational research with regard to characterization of drug transporters.University of CologneCDER
Nisha Bruce
(301) 796-2600
06/30/2014Indefinite
225-15-001Development of scientific collaborations, outreach and educational initiatives, and intellectual partnerships.University of Texas Southwestern Medical CenterSau Larry Lee, Ph.D.
(301) 796-2905
10/22/14 
225-15-002Collaboration to promote these shared interests, which can be pursued through information sharing in regulatory science research, training, sabbaticals, postdoctoral fellowships, and student internships.University of Massachusetts AmherstORA/WEAC
Brian L. Baker
(871) 856-9701
09/12/201409/11/2019

225-15-006

Collaboration to promote these shared interests, which can be pursued through information sharing in regulatory science research, training, sabbaticals, postdoctoral fellowships, and student internships.Morehouse School of MedicineOMH
Jonca Bull
(301) 796-8000
12/22/2014Indefinite
225-16-001
Identify indicators of cardiovascular risk, predict adverse cardiovascular events associated with therapeutic interventions, and improve the clinical utility of biomarker technologies as diagnostic and assessment tools that facilitate developing safer and more effective cardiovascular therapies, diagnostic and assessment tools.
Duke University Cardiac Safety Research ConsortiumNorman Stockbridge, MD, PhD
(301) 796-9841
10/28/2015Indefinite
225-16-005
Establish opportunities for scientific and medical exchange between the FDA scientific staff and the University’s science students and academicians through collaborative research and training.
University of RochesterOCS
Eileen Parish, M.D.
(301) 796-8522 
12/14/20152/13/2020
225-16-006Establish a mutually acceptable agreement between FDA and Cornell that will provide for collaboration on the development and delivery of training to FDA and State, Local, Tribal and Territorial inspection personnel.Cornell UniversityKaren W. Pane
(301) 796-4301
Patricia L. Alcock
(301) 796-4299
12/15/201512/14/2020
225-16-014Promote scientific capital, training, research, training, and research expertise. Information sharing in regulatory science research, training, sabbaticals, postdoctoral, recruitment opportunities, fellowships, and student internships.Rutgers UniversityORA
Paula Davy
(718) 340-7942
Nazmul Hassan
(718) 62-5707
01/26/201601/25/2021
225-16-021
Establishes terms for collaboration through a variety of programs, e.g., research, graduate student training, and exchange of scientists, exchange of staff, sabbaticals, post-doctoral fellowships, and student interns.
Worcester Polytechnic Institute

Gerald J. Dal Pan, MD, MHS, CDER  301706-2380

08/25/2016Indefinite
 
 

Page Last Updated: 08/29/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.